These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10566685)

  • 1. Correction of hyperandrogenemia by laparoscopic ovarian cautery in women with polycystic ovarian syndrome is not accompanied by improved insulin sensitivity or lipid-lipoprotein levels.
    Lemieux S; Lewis GF; Ben-Chetrit A; Steiner G; Greenblatt EM
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4278-82. PubMed ID: 10566685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The laparoscopic ovarian electrocautery versus gonadotropin therapy in infertile women with clomiphene citrate-resistant polycystic ovary syndrome; a randomized controlled trial.
    Mehrabian F; Eessaei F
    J Pak Med Assoc; 2012 Mar; 62(3 Suppl 2):S42-4. PubMed ID: 22768457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a new surgical approach for the treatment of clomiphene citrate-resistant infertility in polycystic ovary syndrome: laparoscopic ovarian multi-needle intervention.
    Kaya H; Sezik M; Ozkaya O
    J Minim Invasive Gynecol; 2005; 12(4):355-8. PubMed ID: 16036198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor alpha versus LH and androstendione as a reliable predictor of spontaneous ovulation after laparoscopic ovarian drilling for women with clomiphene citrate resistance polycystic ovarian disease.
    Seyam E; Hefzy E
    Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():126-133. PubMed ID: 29408743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of laparoscopic ovarian drilling on flow mediated dilation in women with PCOS: relationship with insulin resistance and IGF-I.
    Shokeir T; El-Kannishy G
    Minerva Ginecol; 2014 Apr; 66(2):209-18. PubMed ID: 24848079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Troglitazone therapy improves endothelial function to near normal levels in women with polycystic ovary syndrome.
    Paradisi G; Steinberg HO; Shepard MK; Hook G; Baron AD
    J Clin Endocrinol Metab; 2003 Feb; 88(2):576-80. PubMed ID: 12574183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laparoscopic ovarian drilling in the treatment of polycystic ovary syndrome: how many punctures per ovary are needed to improve the reproductive outcome?
    Malkawi HY; Qublan HS
    J Obstet Gynaecol Res; 2005 Apr; 31(2):115-9. PubMed ID: 15771636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered composition of high density lipoproteins in women with the polycystic ovary syndrome.
    Rajkhowa M; Neary RH; Kumpatla P; Game FL; Jones PW; Obhrai MS; Clayton RN
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3389-94. PubMed ID: 9329374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of ovulation in infertile women with hyperandrogenism and insulin resistance.
    Barbieri RL
    Am J Obstet Gynecol; 2000 Dec; 183(6):1412-8. PubMed ID: 11120504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dyslipidemia with particular regard to apolipoprotein profile in association with polycystic ovary syndrome: a study among Indian women.
    Maitra A; Pingle RR; Menon PS; Naik V; Gokral JS; Meherji PK
    Int J Fertil Womens Med; 2001; 46(5):271-7. PubMed ID: 11720200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of combined metformin-letrozole in comparison with bilateral ovarian drilling in clomiphene-resistant infertile women with polycystic ovarian syndrome.
    Abd Elgafor I
    Arch Gynecol Obstet; 2013 Jul; 288(1):119-23. PubMed ID: 23361456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
    Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
    Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laparoscopic ovarian drilling for clomiphene-resistant polycystic ovary syndrome.
    Flyckt RL; Goldberg JM
    Semin Reprod Med; 2011 Mar; 29(2):138-46. PubMed ID: 21437828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation.
    Moghetti P; Castello R; Negri C; Tosi F; Perrone F; Caputo M; Zanolin E; Muggeo M
    J Clin Endocrinol Metab; 2000 Jan; 85(1):139-46. PubMed ID: 10634377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of insulin resistance on the outcome of laparoscopic ovarian electrocautery in infertile women with the polycystic ovary syndrome.
    Dale PO; Tanbo T; Ertzeid G; Bjercke S; Oldereid N; Fedorcsák P; Abyholm T
    Gynecol Endocrinol; 2004 Oct; 19(4):182-9. PubMed ID: 15724800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperandrogenemia in polycystic ovary syndrome: exploration of the role of free testosterone and androstenedione in metabolic phenotype.
    Lerchbaum E; Schwetz V; Rabe T; Giuliani A; Obermayer-Pietsch B
    PLoS One; 2014; 9(10):e108263. PubMed ID: 25310562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized controlled trial of the effect of rosiglitazone and clomiphene citrate versus clomiphene citrate alone in overweight/obese women with polycystic ovary syndrome.
    Mohsen IA
    Gynecol Endocrinol; 2012 Apr; 28(4):269-72. PubMed ID: 21970545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal ovulatory women with polycystic ovaries have hyperandrogenic pituitary-ovarian responses to gonadotropin-releasing hormone-agonist testing.
    Chang PL; Lindheim SR; Lowre C; Ferin M; Gonzalez F; Berglund L; Carmina E; Sauer MV; Lobo RA
    J Clin Endocrinol Metab; 2000 Mar; 85(3):995-1000. PubMed ID: 10720029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II type 2 receptor stimulation improves fatty acid ovarian uptake and hyperandrogenemia in an obese rat model of polycystic ovary syndrome.
    Leblanc S; Battista MC; Noll C; Hallberg A; Gallo-Payet N; Carpentier AC; Vine DF; Baillargeon JP
    Endocrinology; 2014 Sep; 155(9):3684-93. PubMed ID: 24971613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.